KesslerRCMcGonagleKAZhaoS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.
GreenbergPEKesslerRCBirnbaumHG. The economic burden of depression in the United States: how did it change between 1990 and 2000?J Clin Psychiatry. 2003;64(12):1465–1475.
4.
NorredamMAlbumD. Prestige and its significance for medical specialties and diseases. Scand J Public Health. 2007;35(6):655–661.
5.
PinsonLGrayGE. Psychopharmacology: number needed to treat: an underused measure of treatment effect. Psychiatr Serv. 2003;54(2):145–146.
